Results 121 to 130 of about 4,104 (188)

Osilodrostat (LCI699), a potent 11β-hydroxylase inhibitor, administered in combination with the multireceptor-targeted somatostatin analog pasireotide: A 13-week study in rats

open access: hybrid, 2015
Li Li   +8 more
openalex   +1 more source

Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study. [PDF]

open access: yesPituitary
Mazzeo P   +8 more
europepmc   +1 more source

Management of Non-Islet Cell Tumor Hypoglycemia Induced by Adrenal Cortical Carcinoma. [PDF]

open access: yesJCEM Case Rep
Tang Y   +5 more
europepmc   +1 more source

The efficacy of pasireotide treatment in a patient with Crooke cell adenoma [PDF]

open access: diamond
Katarzyna Maliszewska   +5 more
openalex   +1 more source

A phase I, open-label study of pasireotide in patients with BRAF- and NRAS-wild type, unresectable and or metastatic melanoma [PDF]

open access: bronze, 2016
Reinhard Dummer   +9 more
openalex   +1 more source

Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Zhu X   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy